The review summarizes published data and presents original results that illustrate the variety of antiallergic properties of second generation antihistamine drugs. General notions of inverse agonists of H1-receptors and features of the receptor–ligand interaction that maintain H1-receptors in the non-active state are considered. The broadening of clinical indications for the administration of inverse agonists of H1-receptors aimed at preventing the exacerbation of allergic (atopic) disorders and inhibiting allergic inflammation processes is justified.
Similar content being viewed by others
References
I. S. Gushchin, Allergic Inflammation and its Pharmacological Control [in Russian], Farmarus Print, Moscow (1998).
I. S. Gushchin, Ter. Arkh., No. 10, 27 – 34 (1997).
I. S. Gushchin, Antihistamine Drugs as Histamine Releasers and Inhibitors of its Release, in: Pathogenesis of Allergic Processes in Experiments and the Clinic [in Russian], Meditsina, Moscow (1979), pp. 118 – 131.
I. S. Gushchin, A. I. Zebrev, V. G. Chitaeva, et al., Khim.-farm. Zh., 21, 1313 – 1317 (1987).
I. S. Gushchin, Klin. Farmakol. Ter., No. 3, 82 – 86 (1998).
B. Lebrun-Vignes, B. Diquet, O. Chosidow, et al., Clin. Pharmacokinet., 40, 501 – 507 (2001).
S. Fantin, J. Maspero, C. Bisbal, et al., Allergy, 63, 924 – 931 (2008).
C. Bachert, P. Kuna, F. Sanquer, et al., Allergy, 64, 158 – 165 (2009).
F. W. Fraunfelder, Drugs Today, 40, 677 – 683 (2004).
M. B. Abelson, Expert Opin. Pharmacother., 5, 1979 – 1994 (2004).
J. Mullol, J. Bousquet, C. Bachert, et al., Allergy, 63(87), 5 – 28 (2008).
F. E. R. Simons, ed., Histamine and H 1 -Receptor Antagonists in Allergic Disease, Marcel Dekker, Inc., New York (1996).
U. Gether, Endocr. Rev., 21, 90 – 113 (2000).
M. Le Coniat, E. Traifford, M. Ruat, et al., Hum. Genet., 94, 186 – 188 (1994).
B. Kuhn, A. Schmid, C. Harteneck, et al., Mol. Endocrinol., 10, 1697 – 1707 (1996).
R. A. Bakker, S. B. J. Schoonus, M. J. Smit, et al., Mol. Pharmacol., 60, 1133 – 1142 (2001).
M. Karin, Oncogene, 18, 6867 – 6874 (1999).
O. Hu, S. Deshpande, K. Irani, et al., J. Biol. Chem., 274, 33995 – 33998 (1999).
L. A. Hart, V. L. Krishnan, I. M. Adcock, et al., Am. J. Respir. Crit. Care Med., 158, 1585 – 1592 (1998).
C. Desmet, P. Gosset, B. Pajak, et al., J. Immunol., 173, 5766 – 5775 (2004).
M. E. Poynter, R. Cloots, and T. Van Woerkom, J. Immunol., 173, 7003 – 7009 (2004).
M. C. Catley, J. E. Chivers, N. S. Holden, et al., Br. J. Pharmacol., 145, 114 – 122 (2005).
E. L. Bakkouri, A.Wullaert, M. Haegman, et al., J. Biol. Chem., 280, 17938 – 17944 (2005).
H. J. Na, P. D. Moon, S. G. Ko, et al., J. Pharmacol. Sci. (Tokyo, Jpn), 97, 219 – 226 (2005).
Y. Peng, M. R. Power, B. Li, and T. J. Lin, J. Leukocyte Biol., 77, 975 – 983 (2005).
G. Caramori, I. M. Adcock, and K. Ito, Curr. Opin. Invest. Drugs, 5, 1141 – 1147 (2004).
J. Buddenkotte, C. Stroh, I. H. Engels, et al., J. Invest. Dermatol., 124, 38 – 45 (2005).
K. Asano, K. I. Kanai, and H. Suzaki, Clin. Exp. Allergy, 34, 1890 – 1898 (2004).
M. R. Edwards, N. Mukaida, M. Johnson, and S. L. Johnston, Pulm. Pharmacol. Ther., 18, 337 – 345 (2005).
B. A. Chowdhury and M. A. Kaliner, Molecular Identification of the H 1 -Receptor in Humans, in: Histamine and H 1 -Receptor Antagonists in Allergic Disease, F. E. R. Simons, ed., Marcel Dekker, Inc., New York (1996), pp. 33 – 60.
M. Bruysters, A. Jongejan, M. Gillard, et al., Mol. Pharmacol., 67, 1045 – 1052 (2005).
M. Church, J. World Allergy Organization, 16, 112 – 116 (2004).
R. Leurs, M. K. Church, and M. Taglialatela, Clin. Exp. Allergy, 32, 489 – 498 (2002).
R. A. Bakker, K.Wieland, H. Timmerman, and R. Leurs, Eur. J. Pharmacol., 387, R5–R7 (2000).
M. Govoni, R. A. Bakker, I. van de Wetering, et al., J. Med. Chem., 46, 5812 – 5824 (2003).
I. S. Gushchin, Ross. Allergol. Zh., No. 2, 3 – 14 (2006).
M. Gillard, M. Strolin Benedetti, P. Chatelain, and E. Baltes, Inflammation Res., 54, 367 – 369 (2005).
A. del Cuvillo, J. Millol, J. Bartra, et al., J. Invest. Allergol. Clin. Immunol., 16(1), 3 – 12 (2006).
J. O. Warner, J. Allergy Clin. Immunol., 108, 929 – 937 (2001).
F. E. R. Simons, Pediatr. Allergy Immunol., 18, 535 – 542 (2007).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 44, No. 1, pp.3–8, January, 2010.
Rights and permissions
About this article
Cite this article
Gushchin, I.S. Inverse agonists of H1-receptors as promising antiallergy agents (a review). Pharm Chem J 44, 1–6 (2010). https://doi.org/10.1007/s11094-010-0386-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-010-0386-9